Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nicolas Delanoy
Observed names:
Delanoy, Nicolas,
N. Delanoy
Institutions:
Hôpital Européen Georges-Pompidou,
Hôpital Paris Saint-Joseph
Observed institutions:
Université Paris Cité,
Université Paris-Saclay,
Institut Gustave Roussy,
Sorbonne Paris Cité,
Assistance Publique – Hôpitaux de Paris,
Hôpital Européen Georges-Pompidou,
Hôtel-Dieu de Paris,
Hôpital Paris Saint-Joseph,
Université Paris Descartes
show all 9
ORCID:
0000-0002-8286-7868
Observed ORCID:
0000-0002-8286-7868
OpenAlex ID:
A5085695642
Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study
2018
·
Nicolas Delanoy
, Jean-Marie Michot
, et al.
·
The Lancet Haematology
·
325
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
2023
·
Ana Oaknin
, Laurence Gladieff
, et al.
·
The Lancet
·
270
PDF
Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer
2014
·
Antoine Angelergues
, Denis Maillet
, et al.
·
European Journal of Cancer
·
56
Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database
2018
·
Nicolas Delanoy
, Anne-Claire Hardy-Bessard
, et al.
·
European Urology Oncology
·
31
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network
2020
·
F. Derquin
, A. Floquet
, et al.
·
Gynecologic Oncology
·
27
PDF
The impact of the Paris terrorist attacks on the mental health of resident physicians
2019
·
Jules Gregory
, Jean de Lepinau
, et al.
·
BMC Psychiatry
·
27
PDF
Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study
2021
·
Maud Velev
, Alicja Puszkiel
, et al.
·
Pharmaceuticals
·
26
PDF
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial
2023
·
Gwénaël Ferron
, Gaëtan De Rauglaudre
, et al.
·
Gynecologic Oncology
·
25
Clinical progression at initiation of a life-extending therapy (LET) in metastatic castration-resistant prostate cancer (mCRPC) is associated with a poor prognosis, whatever the treatment-line: Results of the CATS retrospective registry.
2019
·
Nicolas Delanoy
, Anne-Claire Hardy-Bessard
, et al.
·
Journal of Clinical Oncology
·
25
Bleomycin-Induced Pneumonitis in the Treatment of Ovarian Sex Cord–Stromal Tumors
2015
·
Nicolas Delanoy
, Nicolas Pécuchet
, et al.
·
International Journal of Gynecological Cancer
·
23
Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor–Targeted Agents
2018
·
Antoine Angelergues
, Eleni Efstathiou
, et al.
·
Clinical Genitourinary Cancer
·
22
Duration of response to androgen-deprivation therapy (ADT) and efficacy of secondary hormone therapy, docetaxel (D), and cabazitaxel (C) in metastatic castration-resistant prostate cancer (mCRPC).
2014
·
Antoine Angelergues
, Denis Maillet
, et al.
·
Journal of Clinical Oncology
·
20
Nephrotoxicity Associated With Niraparib
2020
·
Hélène Lazareth
, Nicolas Delanoy
, et al.
·
American Journal of Kidney Diseases
·
19
PDF
Discovery and validation of a transcriptional signature identifying homologous recombination-deficient breast, endometrial and ovarian cancers
2022
·
Guillaume Beinse
, Pierre-Alexandre Just
, et al.
·
British Journal of Cancer
·
16
What can we learn from the 10 mm lymph node size cut-off on the CT in advanced ovarian cancer at the time of interval debulking surgery?
2021
·
Louise Benoit
, Jonathan Zerbib
, et al.
·
Gynecologic Oncology
·
14
PDF
Risks and benefits of systematic lymphadenectomy during interval debulking surgery for advanced high grade serous ovarian cancer
2021
·
Louise Benoit
, Meriem Koual
, et al.
·
European Journal of Surgical Oncology
·
11
PDF
Clinical Impact of Lymphadenectomy after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Review of Available Data
2021
·
Stephanie Seidler
, Meriem Koual
, et al.
·
Journal of Clinical Medicine
·
11
PDF
Impact of progression at baseline and on-treatment progression events in three large prostate cancer trials
2019
·
Debbie G. Robbrecht
, Nicolas Delanoy
, et al.
·
European Journal of Cancer
·
11
Development and validation of a RNAseq signature for prognostic stratification in endometrial cancer
2022
·
Guillaume Beinse
, Marie-Aude Le Frere Belda
, et al.
·
Gynecologic Oncology
·
10
PDF
Cabazitaxel Schedules in Metastatic Castration-Resistant Prostate Cancer: A Review
2020
·
Cedric Pobel
, Edouard Auclin
, et al.
·
Future Oncology
·
10
Real-world dostarlimab use in advanced/recurrent endometrial cancer in France
2023
·
Manuel Rodrigues
, Lauriane Eberst
, et al.
·
Bulletin du Cancer
·
9
Prognostic impact of cytoreductive surgery conducted with primary intent, versus cytoreductive surgery after neoadjuvant chemotherapy, in the management of patients with advanced epithelial ovarian cancers: a multicentre, propensity score‐matched study from the FRANCOGYN group
2023
·
Henri Wohrer
, Meriem Koual
, et al.
·
BJOG An International Journal of Obstetrics & Gynaecology
·
9
PDF
727P Phase Ib INEOV neoadjuvant trial of the anti-PDL1, durvalumab (D) +/- anti-CTLA4 tremelimumab (T) with platinum chemotherapy for patients (pts) with unresectable ovarian cancer (OC): A GINECO study
2021
·
A. Leary
, T. De La Motte Rouge
, et al.
·
Annals of Oncology
·
9
PDF
Pharmaceutical consultation to detect drug interactions in patients treated with oral chemotherapies: A descriptive cross‐sectional study
2020
·
Célia Lachuer
, Germain Perrin
, et al.
·
European Journal of Cancer Care
·
9
PDF
Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA Study
2021
·
Nicolas Delanoy
, Debbie Robbrecht
, et al.
·
Cancers
·
8
PDF
Show more works
View as search
Works count:
73
Citation count:
1,095
H-index:
14
I10-index:
20
Year
Topic
Type